TIS 0.00% 0.0¢ tissue therapies limited

Investing, page-20

  1. 55 Posts.
    I'm with you timkiely, I largely made my investment based on the track record and good reputation of Alan Gray in the biotech space. I also took their involvement and participation in the most recent rights issue as a good sign. I would be surprised if they did not play a part in the recent board changes as they appear to be as caught off guard as the rest of the retail SHs.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.